Gpi announces that it signed new international contracts worth more than EUR 5 million in the second quarter of 2023. Its flagship technology products are winning over international customers, from the HIS software for triage in Austria to the T1 monitor, the sensor for telemedicine at Umana Medical in China, to robots for pharmacy automation and transfusion software.
Noteworthy a Riedl Phasys automation contract in China for over EUR 1.4 mln and a new donor transfusion centre in Texas.
Exploring new horizons: innovation, integration, and international growth
A scientific study has been published on an innovative AI system for early skin cancer detection.
STRATEGIC HORIZONS: Gpi’s Industrial Plan 2025 – 2029